Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Roche and GE Healthcare to Explore Personalized Medicine in Patients with Alzheimer's Disease
- BASEL, Switzerland & CHALFONT ST. GILES, England -- Roche and GE Healthcare, a division of the General Electric Company (NYSE:GE), today announced a collaboration aimed at developing personalized care for patients with Alzheimer's disease. In controlled clinical trials, patients taking a Roche anti-amyloid drug candidate for Alzheimer's disease will be...
- Research articles 2005-07-11
- Elan and Wyeth Dose First Patient in North America in Phase 3 Program for Bapineuzumab in Alzheimer's Disease
- DUBLIN, Ireland & COLLEGEVILLE, Pa. -- Elan Corporation, plc (NYSE: ELN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the first patient in North America NA has been dosed as part of a global Phase 3 clinical program for bapineuzumab (AAB-001) in patients with mild to...
- Research articles 2007-12-21
- Statin Drug Potential for Alzheimer's Disease Bolstered by Recent Studies; Nymox (NASDAQ: NYMX) Has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease.
- HASBROUCK HEIGHTS, N.J., Feb 10, 2006 CCNMatthews via COMTEX -- The potential for statin drugs to treat or reduce the risk of Alzheimer's disease AD has been bolstered by several recently published studies and reviews in leading medical and scien HASBROUCK HEIGHTS, N.J., Feb 10, 2006...
- Research articles 2006-02-10
- Eunoe Initiates Alzheimer's Disease Clinical Trial; Indiana University Medical Center Begins Patient Enrollment
- Business Editors & Health/Medical Writers
- Research articles 2001-11-13
- Pfizer Canada and Saskatchewan Health Partner to Improve Access to Treatment for Patients with Alzheimer's Disease in Saskatchewan Saskatchewan Health provides payment for medication for eligible residents of Saskatchewan with mild to moderate Alzheimer's
- REGINA, Saskatchewan, Oct 24, 2000 REGINA, Saskatchewan, Oct 24, 2000
- Research articles 2000-10-25
- Husband of missing Alzheimer's patient to sue American Airlines
- AIRLINE INDUSTRY INFORMATION-C1997-2002 M2 COMMUNICATIONS LTD
- Research articles 2002-04-22
- Statins May Slow the Effects of Alzheimer's Disease According to New Study; Nymox (NASDAQ: NYMX) Has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease.
- HASBROUCK HEIGHTS, N.J., Nov 18, 2005 CCNMatthews via COMTEX -- Cholesterol-lowering drugs like statins were found to slow the progression of Alzheimer's disease AD in a new three year study of 342 AD patients (J. Neurol. Neurosurg. Psychiatry De HASBROUCK HEIGHTS, N.J., Nov 18, 2005 (CCNMatthews...
- Research articles 2005-11-18
- Project study to look at managed care role
- RAQUEL SANTIAGO The Cleveland Area Alzheimer's Association and Kaiser Permanente are teaming up to study the effect of managed care on the quality and cost of caring for patients with Alzheimer's disease and dementia. The three-year study is being finRAQUEL SANTIAGO The Cleveland Area Alzheimer's...
- Research articles 1998-04-27
- Wyeth, Elan and Bapineuzumab -- How to Lie With (Drug) Statistics
- In what is becoming a sadly common ritual, Wyeth and Elan are pressing forward with an expensive, large-scale "phase III" trial of a risky drug based on wishful thinking and shoddy statistical analysis. The drug in question is bapineuzumab, a monoclonal antibody intended to treat Alzheimer's disease...
- Blog posts 2008-07-29
- << Previous
- page 1 of 1
- Next >>
